Search results
Michael Rosenblatt, M.D., is a Senior Advisor at Flagship Pioneering and serves as an independent director on a number of Flagship company boards and provides guidance to Flagship and Flagship companies.
Michael Rosenblatt, M.D., has held major leadership roles in academia and the biopharmaceutical industry, and currently serves as Senior Partner of Flagship Pioneering in Cambridge, MA. Dr. Rosenblatt was Chief Medical Officer (CMO) for Merck from 2009-2016.
The Law Office of Michael A. Rosenblatt is a family law firm in New Orleans, Louisiana. Since 2006, the Michael Rosenblatt Law Firm has served clients around the New Orleans area and earned a reputation for honest, high-quality legal guidance.
The venture capital group Flagship Ventures has now named Michael Rosenblatt as Chief Medical Officer to help its portfolio of companies fill that experience gap. Rosenblatt was Chief Medical Officer at Merck & Co. for 7 years prior to this role, and Dean of Tufts University School of Medicine before that.
Michael Rosenblatt is a Senior Partner of Flagship Pioneering, a venture capital firm that aims to build life sciences companies focused on human health and sustainability.
Jul 13, 2016 · Dr. Rosenblatt was named Senior Vice President for Research at Merck, Sharpe & Dohme Research Laboratories in 1984, and spent nearly a decade at Merck, co-leading the worldwide development team for alendronate (FOSAMAX), Merck's bisphosphonate for osteoporosis and bone disorders.
DR. MICHAEL ROSENBLATT. Senior Partner, Flagship Pioneering. Harvard Medical School Board of Fellows. Dr. Rosenblatt’s career has been in academia, the pharmaceutical industry and biotech/venture. He is a physician, scientist, educator and leader in healthcare.
